Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 940152011000036113 | amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 940153011000036118 | amlodipine 5 mg + hydrochlorothiazide 12.5 mg + valsartan 160 mg tablet, 14 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 14 | has MPUU | amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | 1 | |
| amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 14 | Is a | amlodipine 5 mg + valsartan 160 mg tablet, 14 | true | Inferred relationship | Some | ||
| amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 14 | Is a | valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 14 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amlodipine/Valsartan/HCT 5/160/12.5 (Novartis) tablet, 14 | Is a | True | amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 14 | Inferred relationship | Some | |
| Exforge HCT 5/160/12.5 tablet, 14 | Is a | True | amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 14 | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
Medicinal product pack reference set
FHIR